WEDNESDAY, May 9 (HealthDay News) - In some end-stage heart failure patients awaiting transplant, implantable heart pumps can improve heart function enough to enable them to be discharged from hospital without a pump or a new heart, a new U.S. study finds.In end-stage heart failure, the heart weakens, grows larger and shows other signs of deterioration. Implantable left ventricular assist devices (LVADs) pump blood through the body and allow the heart’s main pumping chamber to rest.>>> Discuss This Story
